General Information of Drug (ID: DMEV6Q2)

Drug Name
3-(1H-indol-3-yl)-N-methyl-3-phenylpropan-1-amine
Synonyms CHEMBL487763; 3-(1H-indol-3-yl)-N-methyl-3-phenylpropan-1-amine; SCHEMBL2074218; HYXMIUGYZHSSJS-UHFFFAOYSA-N; BDBM50275378
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 264.4
Logarithm of the Partition Coefficient (xlogp) 3.7
Rotatable Bond Count (rotbonds) 5
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 1
Chemical Identifiers
Formula
C18H20N2
IUPAC Name
3-(1H-indol-3-yl)-N-methyl-3-phenylpropan-1-amine
Canonical SMILES
CNCCC(C1=CC=CC=C1)C2=CNC3=CC=CC=C32
InChI
InChI=1S/C18H20N2/c1-19-12-11-15(14-7-3-2-4-8-14)17-13-20-18-10-6-5-9-16(17)18/h2-10,13,15,19-20H,11-12H2,1H3
InChIKey
HYXMIUGYZHSSJS-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
44589528
TTD ID
D0BW0V

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Voltage-gated potassium channel Kv11.1 (KCNH2) TTQ6VDM KCNH2_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors. Bioorg Med Chem Lett. 2008 Dec 1;18(23):6062-6.